BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 17, 2013
View Archived Issues
German grant supports work at Dengue Vaccine Initiative
Read More
Novel glutamate transporter modulator has protective effects in neurological disease models
Read More
Bankruptcy court allows sale of Savient assets to Crealta Pharmaceuticals
Read More
Asahi Kasei Pharma presents promising phase I results for AK-106-001616
Read More
Ampio spins off sexual dysfunction business into new company
Read More
KW-2478 demonstrates clinical activity in relapsed and/or refractory multiple myeloma
Read More
Final phase I lymphoma results presented for antibody-drug conjugates from Genentech
Read More
Japanese researchers present new TNIK inhibitors for cancer
Read More
Bristol-Myers Squibb designs new nAChR agonists
Read More
Sunshine Lake Pharma presents new ALK and c-Met inhibitors
Read More
The University of North Carolina synthesizes novel anticancer agents
Read More
Astrazeneca reports topline results from phase III study of lesinurad in gout
Read More
New GR antagonists prepared by Concept Therapeutics
Read More
Galapagos selects preclinical candidate for cystic fibrosis program
Read More
PharmAthene's SparVax anthrax vaccine program placed on clinical hold
Read More
JRC-LAMP-vax demonstrates safety in phase I trials
Read More
Research grants awarded to three Karolinska Development portfolio companies
Read More
The Jerome Lejeune Foundation provides grants to four U.S. researchers
Read More
Emergent Biosolutions to acquire Cangene
Read More
Japanese collaboration announced for antibody biosimilar development in oncology
Read More
Alnylam begins phase II study of ALN-TTRsc for transthyretin-mediated amyloidosis
Read More
AcelRx and Grunenthal establish commercial collaboration for Zalviso in E.U.
Read More
Cubist reports phase III ceftolozane/tazobactam study results
Read More
Norgine and Innovacell sign licensing agreement for ICEF-15
Read More
HER2 companion diagnostic to identify breast cancer patients for targeted medicines
Read More
Targacept reports topline results from phase IIb study of TC-5619 for schizophrenia
Read More